Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
Negaard
Helene F S
HF
Eilertsen
Anette L
AL
Dahm
Anders
A
Iversen
Per O
PO
Østenstad
Bjørn
B
Sandset
Per M
PM
D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor